In 2006, a clinical islet transplantation trial using the Edmonton protocol (NCT00014911) was published, in which 36 subjects with T1D were enrolled at nine transplant centers for islet transplantation using the Edmonton protocol, with insulin independence and good glycemic control as the endpoint 1 year after transplantation. The gene discussed is INS; the disease is type 1 diabetes mellitus.